Treatments and outcomes for patients with spinal muscular atrophy (SMA) type 2: Findings from RESTORE registry

被引：0
|
作者：
Servais, L. [1 ]
Benguerba, K. [2 ]
De Vivo, D. [3 ]
Kirschner, J. [4 ]
Muntoni, F. [5 ]
Proud, C. [6 ]
Tizzano, E. [7 ]
Quijano-Roy, S. [8 ]
Desguerre, I. [9 ]
Saito, K. [10 ]
Raju, D. [11 ]
LaMarca, N. [11 ]
Sun, R. [11 ]
Anderson, F. [12 ]
Faulkner, E. [11 ]
Finkel, R. [13 ]
机构：
[1] Univ Oxford, Oxford, England
[2] Novartis Gene Therapies Switzerland GmbH, Rotkreuz, Switzerland
[3] Columbia Univ, Irving Med Ctr, New York, NY USA
[4] Univ Med Ctr Freiburg, Freiberg, Germany
[5] UCL, London, England
[6] Childrens Hosp Kings Daughters, Norfolk, VA USA
[7] Hosp Valle De Hebron, Barcelona, Spain
[8] Raymond Poincare Univ Hosp, APHP, Garches, France
[9] Hop Necker Enfants Malad, Paris, France
[10] Tokyo Womens Med Univ, Tokyo, Japan
[11] Novartis Gene Therapies Inc, Bannockburn, IL USA
[12] Univ Massachusetts, Med Sch, Worcester, MA USA
[13] St Jude Childrens Res Hosp, Memphis, TN USA
来源：
NEUROMUSCULAR DISORDERS | 2022年 / 32卷
关键词：
D O I：
10.1016/j.nmd.2022.07.189
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.104
引用
收藏
页码：S87 / S87
页数：1
相关论文
共 50 条
  • [1] Treatments and Outcomes for Patients with Spinal Muscular Atrophy (SMA) Type 2: Findings from RESTORE Registry
    Raju, D.
    Servais, L.
    Benguerba, K.
    De Vivo, D.
    Kirschner, J.
    Mercuri, E.
    Muntoni, F.
    Proud, C.
    Tizzano, E.
    Quijano-Roy, S.
    Saito, K.
    Faulkner, E.
    LaMarca, N.
    Sun, R.
    Anderson, F.
    Finkel, R.
    ANNALS OF NEUROLOGY, 2022, 92 : S152 - S153
  • [2] Treatments and Outcomes for Patients with Spinal Muscular Atrophy Type 2: Findings from RESTORE Registry
    Servais, Laurent
    Benguerba, Kamal
    De Vivo, Darryl C.
    Kirschner, Jan
    Muntoni, Francesco
    Proud, Crystal
    Tizzano, Eduardo
    Quijano-Roy, Susana
    Desguerre, Isabelle
    Saito, Kyoko
    Raju, Dheeraj
    LaMarca, Nicole
    Sun, Rui
    Anderson, Fred
    Faulkner, Eric
    Finkel, Richard
    NEUROLOGY, 2023, 100 (17)
  • [3] Real-world treatment patterns and outcomes in patients with spinal muscular atrophy (SMA): Updated findings from the RESTORE Registry
    Servais, L.
    Day, J.
    De Vivo, D.
    Mercuri, E.
    Muntoni, F.
    Shieh, P.
    Tizzano, E.
    Desguerre, I.
    Saito, K.
    Menier, M.
    LaMarca, N.
    Anderson, F.
    Dabbous, O.
    Finkel, R.
    NEUROMUSCULAR DISORDERS, 2021, 31 : S138 - S139
  • [4] The RESTORE Registry: a resource for measuring and improving Spinal Muscular Atrophy (SMA) outcomes
    Servais, L.
    Day, J. W.
    De Vivo, D. C.
    Kirschner, J.
    Mercuri, E.
    Muntoni, F.
    Shieh, P. B.
    Tizzano, E.
    Droege, M.
    Dabbous, O.
    Khan, F.
    Anderson, F. A.
    Finkel, R. S.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 437 - 437
  • [5] The RESTORE registry: a resource for measuring and improving spinal muscular atrophy (SMA) outcomes
    Servais, L.
    Day, J.
    De Vivo, D.
    Kirschner, J.
    Mercuri, E.
    Muntoni, F.
    Shieh, P.
    Tizzano, E.
    Droege, M.
    Dabbous, O.
    Khan, F.
    Anderson, F.
    Finkel, R.
    NEUROMUSCULAR DISORDERS, 2019, 29 : S195 - S195
  • [6] The RESTORE Registry: Real -World Assessments of Interventions and Long -Term Outcomes in Patients with Spinal Muscular Atrophy (SMA)
    Finkel, Richard
    Day, John
    De Vivo, Darryl
    Mercuri, Eugenio
    Muntoni, Francesco
    Shieh, Perry
    Tizzano, Eduardo
    Desguerre, Isabelle
    Saito, Kayoko
    Menier, Melissa
    LaMarca, Nicole
    Anderson, Fred
    Dabbous, Omar
    Servais, Laurent
    NEUROLOGY, 2022, 98 (18)
  • [7] Newborn screening (NBS) for spinal muscular atrophy (SMA) in the United States (US): Early findings from the RESTORE registry
    Servais, L.
    De Vivo, D.
    Kirschner, J.
    Mercuri, E.
    Muntoni, F.
    Tizzano, E.
    Roy, S.
    Saito, K.
    Menier, M.
    LaMarca, N.
    Anderson, F.
    Dabbous, O.
    Finkel, R.
    NEUROMUSCULAR DISORDERS, 2021, 31 : S138 - S138
  • [8] Newborn Screening (NBS) for Spinal Muscular Atrophy (SMA) in the United States (US): Early Findings from the RESTORE Registry
    Servais, L.
    De, Vivo D.
    Kirschner, J.
    Mercuri, E.
    Muntoni, F.
    Tizzano, E.
    Roy, S.
    Saito, K.
    Menier, M.
    LaMarca, N.
    Anderson, F.
    Dabbous, O.
    Finkel, R.
    ANNALS OF NEUROLOGY, 2021, 90 : S152 - S153
  • [9] Outcomes in patients with spinal muscular atrophy (SMA) and four or more SMN2 copies treated with onasemnogene abeparvovec: findings from RESTORE
    Finkel, R.
    Benguerba, K.
    Gehani, M.
    Raju, D.
    Faulkner, E.
    LaMarca, N.
    Servais, L.
    NEUROMUSCULAR DISORDERS, 2023, 33 : S133 - S133
  • [10] Effectiveness and Safety of Onasemnogene Abeparvovec in Older Patients with Spinal Muscular Atrophy (SMA): Real-World Outcomes from the RESTORE Registry
    Servais, Laurent
    De Vivo, Darryl
    Kirschner, Janbernd
    Mercuri, Eugenio
    Muntoni, Francesco
    Tizzano, Eduardo
    Quijano-Roy, Susana
    Saito, Kayoko
    Menier, Melissa
    LaMarca, Nicole
    Anderson, Fred
    Dabbous, Omar
    Finkel, Richard
    NEUROLOGY, 2022, 98 (18)
12345